ARCHIVES

September issue of Business & Regulatory Report included–8 additional pages of industry news.

This article is from The Cancer Letter archive.

Vol. 30 No. 37 | October 1, 2004

Download PDF Visit The Full Archive

Related Articles

BMS, ImClone To Develop New Drug IMC-C225, Targets EGF Receptor.

September 28, 2001

NCI To Fund About 4,100 Grants; Increase Planned In Average Costs; Paylines Stable

November 20, 1998

NCI-Approved Trials Listed

March 30, 2007

In Brief: Day, Foti Lead Coalition; Harkin Ends Campaigns; UT Southwestern Recieves $85 Mil. In Donations

March 13, 1992

NCI Cooperative Group Clinical Trials Approved

October 30, 2009

Treatment Division Outlines Future Program Areas

January 24, 1975